Opaleye Management manages investments for a private fund and a separately managed account, focusing on equity securities of biotechnology, specialty pharmaceutical, and device companies. The firm's investment approach involves analyzing company fundamentals and seeking to profit from clinical, regulatory, or commercial progress. Opaleye may invest in both long and short positions.
Assets Under Management$800M
Clients2
AdvisorsN/A
Avg. per Client$400M
Avg. per AdvisorN/A
Fee Structure
Minimum Investment:$1M
Investment management only (planning not offered)
Opaleye Management charges a monthly management fee of 2% annually, billed monthly in advance. There is also a performance-based allocation of 10% of the first 20% of profits and 20% thereafter, calculated annually and subject to a high-water mark. These fees apply to both the private fund and the managed account.
Loading...
Location
0 Advisors at this firm
No advisors found for this firm.